Brendan P. Eckelman, Chief Scientific Officer, 10% Owner at Inhibrx, Inc. (INBX), sold 77,507 shares at $14.86 ($1.2M) on 2022-09-06, disclosed to the SEC on 2022-09-07.
Open-market sale of $1.2M INBX by Chief Scientific Officer, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.86 | 37,507 | $557K | 48.3% |
| 2 | $14.86 | 37,507 | $557K | 48.3% |
| 3 | $15.66 | 2,493 | $39K | 3.4% |
| Total | $14.89 avg | 77,507 | $1.2M | 100% |
| Filing → |
| INBX | SELL | 2022-12-07 | $2.1M | — | Filing → |
| INBX | SELL | 2022-11-02 | $2.7M | — | Filing → |
| INBX | SELL | 2022-10-05 | $2.2M | — | Filing → |